title: Injection practices in Burkina Faso in 2000.
abstract: BACKGROUND
  Unsafe delivery and overuse of injections can result in the spread of hepatitis B virus, hepatitis C virus, and HIV. The aim of the present survey was to estimate the frequency of safe injection practices in Burkina Faso.
  
  
  METHODS
  Using the new standardized World Health Organization tool to assess injection practices, we selected 80 primary health facilities with a two-stage cluster sampling method, collected information using structured observations and provider interviews, and analyzed the data using Epi-Info software.
  
  
  RESULTS
  We observed 116 injections in 52 facilities. In 50 facilities [96%; 95% confidence interval (CI) 85-99%] injections were given with a new, single-use syringe and needle. In 29 facilities (56%; 95% CI 36-74%), staff recapped needles using two hands. All 80 facilities visited had a stock in the community to provide new, single-use syringes and needles. In 61% (95% CI 54-79%) of facilities, staff reported needlestick injuries in the last 12 months. Used needles were discarded in open containers in 66 facilities (83%; 95% CI 55-96%) and observed in the surroundings of 46 facilities (57%; 95% CI 32-80%).
  
  
  CONCLUSIONS
  In 2000, most of the health facilities in Burkina Faso were using sterile injection equipment. However, practices were still observed that could expose patients, health care workers, and communities to risks, and that required specific interventions.
authors.affiliation: World Health Organization Headquarters, Geneva, Switzerland. fitznerj@lyon.who.int
authors.forename: J
authors.initials: J
authors.lastname: Fitzner
authors.forename: J-F
authors.initials: JF
authors.lastname: Aguilera
authors.forename: A
authors.initials: A
authors.lastname: Yameogo
authors.forename: P
authors.initials: P
authors.lastname: Duclos
authors.forename: Y J F
authors.initials: YJ
authors.lastname: Hutin
mesh_terms: D002050:Burkina Faso; D019983:Guideline Adherence; D006801:Humans; D017053:Infection Control / Q000379:methods* / Q000592:standards; D007267:Injections / Q000009:adverse effects / Q000592:standards*; D011320:Primary Health Care / Q000379:methods / Q000592:standards; D014777:Virus Diseases / Q000517:prevention & control* / Q000635:transmission; D014944:World Health Organization